Review




Structured Review

Dexcom Inc dexcom g6 pro cgm
Dexcom G6 Pro Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cgm+system+dexcom+g6/dexcom+g6+pro+%E2%80%A2/pm42251767-53-1-5
Average 86 stars, based on 1 article reviews
dexcom g6 pro cgm - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

Membrane:

Article Title: Electrocardiograpic responses during spontaneous hypoglycaemia in people with type 1 diabetes and impaired awareness of hypoglycaemia
Article Snippet: Participants also had a time‐synchronised CGM system attached (Dexcom G6; Dexcom Inc., San Diego, California, USA) in a blinded mode.

Article Title: Developing a multicomponent intervention to increase glucose time in range in adolescents and young adults with type 1 diabetes: An optimisation trial to screen continuous glucose monitoring, sleep extension, healthier snacking and values-guided self-management intervention components.
Article Snippet: The CGM component used the Dexcom G6 CGM system (Dexcom, Inc., San Diego, CA, USA) connected to a personal mobile device and included CGM education, personalised feedback on pre-intervention CGM data, goal setting (70 % of values between 3.9 and 10.0 mmol/L [2]), and a 2-week CGM data review.

Article Title: Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin-treated diabetes: A randomised, open-label, crossover trial.
Article Snippet: Participants were provided with a CGM system (Dexcom G6; Dexcom, San Diego, CA), measuring real-time glucose concentrations (2.2–22.2 mmol/L) at five-minute intervals.

Article Title: Toward Detection of Nocturnal Hypoglycemia in People With Diabetes Using Consumer-Grade Smartwatches and a Machine Learning Approach.
Article Snippet: Each participant was equipped with an unblinded CGM system (Dexcom G6 or G7).

Article Title: Predicting the Risk of Adverse Neonatal Outcomes in Women With Insulin-Treated Diabetes: Is It Time for a Pregnancy-Specific Glycemic Risk Index (GRI)?
Article Snippet: Background: The Glycemia Risk Index (GRI) describes the quality of glycemic control, emphasizing extreme hypoglycemia and hyperglycemia more than less extreme values.. However, a pregnancy-specific GRI (pGRI), tailored to the tighter target glucose range required during pregnancy, has not been established.. Methods: We retrospectively evaluated clinical, metabolic, and Continuous Glucose Monitoring (CGM) data across pregnancy in women with insulin-treated diabetes, managed between September 2021 and March 2024 at the University Hospital of Pisa.

Article Title: Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial
Article Snippet: Participants were provided with a CGM system (Dexcom G6; Dexcom, San Diego, CA), measuring real‐time glucose concentrations (2.2–22.2 mmol/L) at five‐minute intervals.

Article Title: Performance of a Novel Continuous Glucose Monitoring Device in People With Diabetes.
Article Snippet: Background: In this multicenter study, performance of a novel continuous glucose monitoring (CGM) system was evaluated.. Methods: Adult participants with diabetes were included in the study.. They each wore three sensors of the CGM system on the upper arms for up to 14 days.

Sampling:

Article Title: Electrocardiograpic responses during spontaneous hypoglycaemia in people with type 1 diabetes and impaired awareness of hypoglycaemia
Article Snippet: Participants also had a time‐synchronised CGM system attached (Dexcom G6; Dexcom Inc., San Diego, California, USA) in a blinded mode.

Article Title: Developing a multicomponent intervention to increase glucose time in range in adolescents and young adults with type 1 diabetes: An optimisation trial to screen continuous glucose monitoring, sleep extension, healthier snacking and values-guided self-management intervention components.
Article Snippet: The CGM component used the Dexcom G6 CGM system (Dexcom, Inc., San Diego, CA, USA) connected to a personal mobile device and included CGM education, personalised feedback on pre-intervention CGM data, goal setting (70 % of values between 3.9 and 10.0 mmol/L [2]), and a 2-week CGM data review.

Article Title: Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin-treated diabetes: A randomised, open-label, crossover trial.
Article Snippet: Participants were provided with a CGM system (Dexcom G6; Dexcom, San Diego, CA), measuring real-time glucose concentrations (2.2–22.2 mmol/L) at five-minute intervals.

Article Title: Toward Detection of Nocturnal Hypoglycemia in People With Diabetes Using Consumer-Grade Smartwatches and a Machine Learning Approach.
Article Snippet: Each participant was equipped with an unblinded CGM system (Dexcom G6 or G7).

Article Title: Predicting the Risk of Adverse Neonatal Outcomes in Women With Insulin-Treated Diabetes: Is It Time for a Pregnancy-Specific Glycemic Risk Index (GRI)?
Article Snippet: Background: The Glycemia Risk Index (GRI) describes the quality of glycemic control, emphasizing extreme hypoglycemia and hyperglycemia more than less extreme values.. However, a pregnancy-specific GRI (pGRI), tailored to the tighter target glucose range required during pregnancy, has not been established.. Methods: We retrospectively evaluated clinical, metabolic, and Continuous Glucose Monitoring (CGM) data across pregnancy in women with insulin-treated diabetes, managed between September 2021 and March 2024 at the University Hospital of Pisa.

Article Title: Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial
Article Snippet: Participants were provided with a CGM system (Dexcom G6; Dexcom, San Diego, CA), measuring real‐time glucose concentrations (2.2–22.2 mmol/L) at five‐minute intervals.

Article Title: Performance of a Novel Continuous Glucose Monitoring Device in People With Diabetes.
Article Snippet: Background: In this multicenter study, performance of a novel continuous glucose monitoring (CGM) system was evaluated.. Methods: Adult participants with diabetes were included in the study.. They each wore three sensors of the CGM system on the upper arms for up to 14 days.

Control:

Article Title: Electrocardiograpic responses during spontaneous hypoglycaemia in people with type 1 diabetes and impaired awareness of hypoglycaemia
Article Snippet: Participants also had a time‐synchronised CGM system attached (Dexcom G6; Dexcom Inc., San Diego, California, USA) in a blinded mode.

Article Title: Developing a multicomponent intervention to increase glucose time in range in adolescents and young adults with type 1 diabetes: An optimisation trial to screen continuous glucose monitoring, sleep extension, healthier snacking and values-guided self-management intervention components.
Article Snippet: The CGM component used the Dexcom G6 CGM system (Dexcom, Inc., San Diego, CA, USA) connected to a personal mobile device and included CGM education, personalised feedback on pre-intervention CGM data, goal setting (70 % of values between 3.9 and 10.0 mmol/L [2]), and a 2-week CGM data review.

Article Title: Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin-treated diabetes: A randomised, open-label, crossover trial.
Article Snippet: Participants were provided with a CGM system (Dexcom G6; Dexcom, San Diego, CA), measuring real-time glucose concentrations (2.2–22.2 mmol/L) at five-minute intervals.

Article Title: Toward Detection of Nocturnal Hypoglycemia in People With Diabetes Using Consumer-Grade Smartwatches and a Machine Learning Approach.
Article Snippet: Each participant was equipped with an unblinded CGM system (Dexcom G6 or G7).

Article Title: Predicting the Risk of Adverse Neonatal Outcomes in Women With Insulin-Treated Diabetes: Is It Time for a Pregnancy-Specific Glycemic Risk Index (GRI)?
Article Snippet: Background: The Glycemia Risk Index (GRI) describes the quality of glycemic control, emphasizing extreme hypoglycemia and hyperglycemia more than less extreme values.. However, a pregnancy-specific GRI (pGRI), tailored to the tighter target glucose range required during pregnancy, has not been established.. Methods: We retrospectively evaluated clinical, metabolic, and Continuous Glucose Monitoring (CGM) data across pregnancy in women with insulin-treated diabetes, managed between September 2021 and March 2024 at the University Hospital of Pisa.

Article Title: Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial
Article Snippet: Participants were provided with a CGM system (Dexcom G6; Dexcom, San Diego, CA), measuring real‐time glucose concentrations (2.2–22.2 mmol/L) at five‐minute intervals.

Article Title: Performance of a Novel Continuous Glucose Monitoring Device in People With Diabetes.
Article Snippet: Background: In this multicenter study, performance of a novel continuous glucose monitoring (CGM) system was evaluated.. Methods: Adult participants with diabetes were included in the study.. They each wore three sensors of the CGM system on the upper arms for up to 14 days.



Similar Products

86
Dexcom Inc dexcom g6 pro cgm
Dexcom G6 Pro Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cgm+system+dexcom+g6/dexcom+g6+pro+%E2%80%A2/pm42251767-53-1-5
Average 86 stars, based on 1 article reviews
dexcom g6 pro cgm - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Dexcom Inc dexcom g6 cgm
Dexcom G6 Cgm, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cgm+system+dexcom+g6/cgm+dexcom+g6/med_rxiv__64898__2026__05__13__26353094-33-8-8
Average 86 stars, based on 1 article reviews
dexcom g6 cgm - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Dexcom Inc dexcom g6 cgm device
Dexcom G6 Cgm Device, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cgm+system+dexcom+g6/dexcom+g6+pro+%E2%80%A2/pm41924857-31-20-20
Average 86 stars, based on 1 article reviews
dexcom g6 cgm device - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Dexcom Inc masked dexcom g6 pro cgm sensors
Masked Dexcom G6 Pro Cgm Sensors, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cgm+system+dexcom+g6/blood+glucose+monitor/10__1097_slash_grf__0000000000001010-27-6-7
Average 86 stars, based on 1 article reviews
masked dexcom g6 pro cgm sensors - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results